tiprankstipranks
Coya Therapeutics provides enrollment update of COYA 302 study
PremiumThe FlyCoya Therapeutics provides enrollment update of COYA 302 study
4M ago
Coya Therapeutics initiated with a Buy at D. Boral Capital
Premium
The Fly
Coya Therapeutics initiated with a Buy at D. Boral Capital
4M ago
Coya Therapeutics files to sell 1.38M shares of common stock for holders
Premium
The Fly
Coya Therapeutics files to sell 1.38M shares of common stock for holders
5M ago
Coya Therapeutics Announces Leadership Change and New CEO
PremiumCompany AnnouncementsCoya Therapeutics Announces Leadership Change and New CEO
6M ago
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results
Premium
Company Announcements
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results
6M ago
Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints
Premium
The Fly
Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints
6M ago
Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
PremiumThe FlyCoya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
8M ago
Coya Therapeutics reports Q2 EPS (19c), consensus (31c)
Premium
The Fly
Coya Therapeutics reports Q2 EPS (19c), consensus (31c)
8M ago
Coya files U.S  patents for COYA 301 + GLP-1 receptor agonists
Premium
The Fly
Coya files U.S patents for COYA 301 + GLP-1 receptor agonists
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100